_________
false
àáåâï áò"î
2
381
EVOGENE LTD
Corporation no:
512838723
10571
Israel Securities Authority
Tel Aviv Stock Exchange
C003
(
Public
)
Reported via MAGNA:
01/05/2018
www.isa.gov.il
www.tase.co.il
Reference:
2018-02-043243
Time of broadcast:
13:54
13:45:22
Other Report or Announcement
Regulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
Delay the publication of a report
_________
_________
1. The delay of the report can be done up to 72 hours maximum from the date of filling out the form.
2. Attention that in accordance with the provisions of the law, the reporting date must be simultaneous with the report in the foreign exchange.
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
Press Release: Biomica, Evogene’s Newly Established Subsidiary, Announces Therapeutic Areas of Focus
Biomica_focus_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
-1
Date of revision of form structure:
20/02/2018
Address:
Gad Feinstein St
13, P.O.B 2100
,
Rehovot
76121
,
Tel:
08-9311900
,
Fax:
08-9466724
E-mail address:
ofer.haviv@evogene.com
Company site:
www.evogene.com
Previous names of reporting entity:
Name of the Signatory:
Masliah Sassi
Position of Signatory in the reporting corporation:
Director of Legal Affairs & Company Secretary
Name of Employer Company:
Address:
Gad Feinstein
13
,
Rehovot
7612001
Telephone:
08-9311901
Facsimile:
08-9466724
E-mail:
sassi.masliah@evogene.com
1